Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...

Novo Nordisk CEO Lars Fruergaard Jørgensen will step down after eight years at the helm, as the Danish pharmaceutical giant ...

Trump is “in peak physical and mental condition,” White House Press Secretary Karoline Leavitt told The Atlantic in an ...

May 16 - As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for a leader deeply entrenched in the United States, by far its ...

To be clear, that concern was well-founded: High drug prices are one reason the U.S. has become a global leader in medical ...

US stocks rose on Friday, notching weekly wins across the major averages after an easing in US-China trade tensions.

Novo Nordisk has filed another Citizen's Petition with the FDA seeking to block compounding pharmacies in the US from making versions of one of its GLP-1 agonist drugs. The latest attempt focuses ...

On Wall Street, Charter Communications rose 1.8% after it said it agreed to merge with Cox Communications in a deal that ...

Eli Lilly (LLY) is a leading pharmaceutical company that discovers, develops, manufactures, and markets healthcare products.

The papers are dominated by better deals expected with the EU and Sir Keir Starmer's pivot on winter fuel payments.

Novo Nordisk is making the case for its diabetes ... The company announced the completion of two trials of its GLP-1 class drug semaglutide, in oral form, this week alongside with impressive ...